Clinical Trial Update: Pravastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating pravastatin with alkali therapy in adults with autosomal dominant polycystic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Dominant Polycystic Kidney Disease

Drugs mentioned

• Pravastatin (pravastatin)
• alkali therapy

Snippet

Sponsor: University of Southern California | Conditions: Autosomal Dominant Polycystic Kidney Disease | Phase 2 | Status: COMPLETED